Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients

NCT00161369 is registered in ClinicalTrials.gov with University of Shizuoka as lead sponsor.

NCT NCT00161369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients
Lead sponsor
University of Shizuoka
Phase
Observational
Overall status
Completed
Start date
April 30, 2000
Completion date
March 31, 2005
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, chronic renal failure, hemodialysis